Anti-GDF10 antibody produced in rabbit，100UL，HPA015498-100UL，Sigma

General description

GDF10 (growth differentiation factor 10) belongs to the family of bone-morphogenetic protein (BMP) family, which in turn belongs to transforming growth factor β (TGFβ) family. BMP is divided into three groups, where GDF10, also called BMP3B, is a member of the third group. This gene maps to human chromosome 10q, contains 3 exons, spans 13kb and the cDNA has 2632bp, which codes for a protein composed of 478 amino acids. N-terminal signal sequence cleavage yields a mature protein composed of 110 amino acids. The transcript is expressed predominantly in brain, lung, femur, pancreas, testis and skeletal muscle.

Immunogen

Bone morphogenetic protein 3b precursor recombinant protein epitope signature tag (PrEST)

Application

All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry.

The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. We also provide Prestige Antibodies^® protocols and other useful information.

Biochem/physiol Actions

GDF10 (growth differentiation factor 10) is epigenetically silenced in multiple cancers such as, colorectal neoplasms and non-small cell lung cancers (NSCLCs). Studies in Japanese population show that this gene is silenced by methylation in malignant pleural mesotheliomas (MPMs). It acts as a tumor suppressor gene in various malignant tumors. It might play a role in the differentiation of various cell types, and might be associated with morphogenesis of skeletal tissues. This gene is regulated by SOX9 and hypoxia-inducible factor.

Features and Benefits

Prestige Antibodies^® are highly characterized and extensively validated antibodies with the added benefit of all available characterization data for each target being accessible via the Human Protein Atlas portal linked just below the product name at the top of this page. The uniqueness and low cross-reactivity of the Prestige Antibodies^® to other proteins are due to a thorough selection of antigen regions, affinity purification, and stringent selection. Prestige antigen controls are available for every corresponding Prestige Antibody and can be found in the linkage section.

Every Prestige Antibody is tested in the following ways:

• IHC tissue array of 44 normal human tissues and 20 of the most common cancer type tissues.
• Protein array of 364 human recombinant protein fragments.

Physical form

Solution in phosphate-buffered saline, pH 7.2, containing 40% glycerol and 0.02% sodium azide

Other Notes

Corresponding Antigen APREST72574

Legal Information

Prestige Antibodies is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.